CoreAge Rx vs TeleClinic
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
TeleClinic
Best for: Transparent, cash-pay compounded GLP-1 from a named 503A pharmacy across 47 states
Visit TeleClinic →CoreAge Rx and TeleClinic are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, CoreAge Rx starts lower at $149/mo versus $199/mo, and CoreAge Rx edges ahead overall (8.3 vs 7.3 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.
Pricing
CoreAge Rx
TeleClinic
Ongoing month-to-month; first-quarter intro $139/mo billed quarterly
Ongoing month-to-month; first-quarter intro $219/mo billed quarterly
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 360+ providers' prices on their own sites and email you when tracked prices move.
What’s included
CoreAge Rx
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
TeleClinic
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
CoreAge Rx
8.3/10
TeleClinic
7.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | CoreAge Rx | TeleClinic |
|---|---|---|
| Starting Price | ✓$149/mo | $199/mo |
| Features | 6 features | 6 features |
| States Available | ✓50 | 47 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About CoreAge Rx
CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.
Read our full CoreAge Rx review →About TeleClinic
TeleClinic (Teleclinic Holdings LLC) is a US telehealth platform offering physician-prescribed compounded GLP-1 weight-loss medication — semaglutide and tirzepatide — shipped from a licensed 503A compounding pharmacy. Programs are cash-pay with no insurance, flat monthly pricing, and free shipping across 47 states. Prescriptions are filled by Rush Pharmacy, a 503A compounder TeleClinic describes as PCAB-accredited. It also offers NAD+ and B12/MIC injections. TeleClinic is LegitScript certified; compounded semaglutide and tirzepatide are not FDA-approved.
Read our full TeleClinic review →Pros & Cons
CoreAge Rx
What we like
- LegitScript certified — rigorous pharmacy standards
- Free 2-day shipping nationwide
- Both semaglutide and tirzepatide available
- Lowest per-month pricing in the compounded segment
- 24/7 support team
- All 50 states covered
Watch-outs
- Compounded only — no brand-name Ozempic or Wegovy
- Newer brand with fewer independent reviews than legacy players
TeleClinic
What we like
- Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
- LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
- Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing
Watch-outs
- Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
- Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
- Not available in California, South Carolina, or New Jersey
Our Verdict
CoreAge Rx edges out TeleClinic with a higher overall score of 8.3/10 and is particularly strong for best overall value. TeleClinic remains a solid alternative, especially if you're looking for Transparent, cash-pay compounded GLP-1 from a named 503A pharmacy across 47 states.
Choose CoreAge Rx if…
You want best overall value and a starting price around $149/mo.
Choose TeleClinic if…
You want Transparent, cash-pay compounded GLP-1 from a named 503A pharmacy across 47 states and a starting price around $199/mo.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Sesame Care
Brand-name GLP-1s (Wegovy, Zepbound) at LillyDirect/NovoCare cash prices — no compounding
From $25/mo
Get started →MEDVi
Patients who want the option to switch between compounded and brand-name GLP-1 through one provider
From $99/mo
Get started →Liv Body
Compounded GLP-1 paired with a muscle-preservation supplement stack
From $179/mo
Get started →CoreAge Rx vs TeleClinic: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring CoreAge Rx and TeleClinic head-to-heads in the same category.
- CoreAge Rx vs Amazon One Medical
- CoreAge Rx vs Vytora Health
- CoreAge Rx vs Found
- TeleClinic vs NewSelf
- TeleClinic vs Elara Health and Wellness
- TeleClinic vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.